What is Post Acute Analytics?
Post Acute Analytics operates as a specialized healthcare technology firm dedicated to the modernization of patient care transitions. By deploying a clinically intelligent platform, the company provides healthcare providers with real-time insights, predictive intelligence, and robust workflow automation. This technological framework is designed to address critical inefficiencies in the post-acute care continuum, effectively reducing avoidable costs while simultaneously enhancing transparency and patient outcomes.
The company occupies a vital niche in the digital health ecosystem, bridging the gap between disparate clinical data sources and actionable operational intelligence. Its platform is engineered to support providers in navigating the complexities of value-based care, ensuring that clinical decisions are backed by rigorous data analysis. As the industry shifts toward more integrated care models, Post Acute Analytics remains a pivotal player in facilitating seamless communication and coordination across the healthcare landscape.
How much funding has Post Acute Analytics raised?
Post Acute Analytics has raised a total of $64.1M across 4 funding rounds:
Series A
$3.7M
Debt
$350K
Series C
$17M
Stock/Share Issuance
$43.1M
Series A (2018): $3.7M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Series C (2022): $17M supported by Generator Ventures, Rubicon Founders, Dorilton Capital, Warburg Pincus, and Concord Health Partners
Stock/Share Issuance (2025): $43.1M, investors not publicly disclosed
Key Investors in Post Acute Analytics
Generator Ventures
Generator Ventures is a specialized venture capital firm focused on identifying and nurturing innovative startups within the healthcare and aging services sectors.
Rubicon Founders
Rubicon Founders is an entrepreneurial healthcare investment firm dedicated to building and growing transformational companies that deliver enduring value in healthcare delivery.
Dorilton Capital
Dorilton Capital Advisors is a family equity office that provides long-term, patient capital to lower middle-market companies, emphasizing sustainable growth and legacy preservation.
What's next for Post Acute Analytics?
With the successful closure of this major enterprise-level funding, Post Acute Analytics is poised to scale its operational footprint and deepen its product capabilities. The strategic roadmap likely involves expanding its predictive intelligence suite to cover a broader range of clinical scenarios and enhancing its interoperability with existing electronic health record systems. By focusing on scalable infrastructure, the company aims to solidify its role as an essential partner for health systems striving to improve quality metrics and financial performance.
Furthermore, the continued backing from institutional investors suggests a long-term commitment to the company's vision of transforming healthcare delivery. Future initiatives will likely prioritize the integration of advanced machine learning models to further refine workflow automation, thereby empowering clinicians to focus on high-impact patient interactions. As the firm matures, its ability to maintain this growth trajectory will be contingent upon its continued success in demonstrating clear, quantifiable ROI for its enterprise clients.
